Clinical Trial Update: Single Ascending Doses Study of KLS-2031 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy [Phase 1, Phase 2]

View source ↗

Summary

This document reports the completion of a combined Phase 1/2 single ascending dose study of KLS-2031 in subjects with neuropathic pain due to lumbosacral radicu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lumbosacral Radiculopathy
• Neuropathic Pain

Drugs mentioned

• KLS-2031

Snippet

Sponsor: Kolon Life Science | Conditions: Neuropathic Pain From Lumbosacral Radiculopathy | Phase 1, Phase 2 | Status: COMPLETED